Marksans Pharma acquires US based Time-Cap Laboratories

30 Jun 2015 Evaluate

Marksans Pharma through its wholly owned subsidiary, Marksans Pharma Inc., has acquired 100% of the outstanding shares of Time-Cap Laboratories, Inc., a New York corporation having its principal office at Farmingdale, New York. With this acquisition, Marksans is strategically increasing its presence in the US market, which is the largest pharmaceutical market in the world.

Time-Cap Laboratories is a leading manufacturer and marketer of solid dose generic pharmaceuticals, including private label over-the-counter (OTC) medications, generic prescription drugs (Rx), and nutritional supplements. It manufactures over 50 unique products from its facility in Farmingdale, New York, including tablets, caplets, capsules and pellets. Time-Cap’s average annual revenue over the last four years is in excess of $30 million per annum, and it achieved an average annual adjusted EBITDA of approximately $4 million. The company presently has no debt.

Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×